Viewing Study NCT02558335


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2026-02-27 @ 11:20 AM
Study NCT ID: NCT02558335
Status: COMPLETED
Last Update Posted: 2020-04-24
First Post: 2015-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CTCs for High Grade Glioma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UPCC 09313
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators